Skip to main content

K Pharma,Inc.

株式会社ケイファーマ

Valuation

Fundamental ratios for the latest reported period.

Ticker: 4896
FY2025 · 2025-12-31
Gross margin
Operating margin
Net margin
Return on equity
Return on assets-33.8%
Revenue growth (YoY)
EPS (basic)¥-85.59
EPS growth (YoY)
Current ratio28.41x
Equity ratio43.1%
Book value / share¥109
Free cash flow-929 M